The efficacy and safety of using different AI values for pulmonary vein isolation in patients with atrial fibrillation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300070653

Enrollment

Unknown

Registered

2023-04-19

Start date

2020-12-05

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

low AI value :different AI value

high AI value:different AI value

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients with symptomatic paroxysmal atrial fibrillation who used Smart-touch catheters for AI-guided quantitative ablation at the participating center from Dec 2020 to June 2021; 2. After full informed consent, the patient or family members are willing to join the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: a) Patients who have undergone radiofrequency ablation of atrial fibrillation before; b) There are conditions such as thrombosis in the atrium and severe spontaneous imaging that are not suitable for radiofrequency ablation; c) LVEF<40% d) Patients with organic heart disease such as congenital heart disease, valvular heart disease, coronary heart disease, cardiomyopathy, etc.

Design outcomes

Primary

Measure	Time frame
the rate of free from atrial fibrillation in 1 year.;first-pass isolation rate;	—

Secondary

Measure	Time frame
The rate of POP;The rate of apoplexy;The rate of pericardial effusion;	—

Countries

China

Contacts

Public ContactXiao-bo Pu

West China Hospital, Sichuan University

35470546@qq.com+86 15881366560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026